Literature DB >> 19047683

A functional calcium-binding site in the metalloprotease domain of ADAMTS13.

Michelle D Gardner1, Chan K N K Chion, Rens de Groot, Anuja Shah, James T B Crawley, David A Lane.   

Abstract

ADAMTS13 regulates the multimeric size of von Willebrand factor (VWF). Its function is highly dependent upon Ca(2+) ions. Using the initial rates of substrate (VWF115, VWF residues 1554-1668) proteolysis by ADAMTS13 preincubated with varying Ca(2+) concentrations, a high-affinity functional ADAMTS13 Ca(2+)-binding site was suggested with K(D(app)) of 80 muM (+/- 15 muM) corroborating a previously reported study. When Glu83 or Asp173 (residues involved in a predicted Ca(2+)-binding site in the ADAMTS13 metalloprotease domain) were mutated to alanine, Ca(2+) dependence of proteolysis of the substrate was unaffected. Consequently, we sought and identified a candidate Ca(2+)-binding site in proximity to the ADAMTS13 active site, potentially comprising Glu184, Asp187, and Glu212. Mutagenesis of these residues within this site to alanine dramatically attenuated the K(D(app)) for Ca(2+) of ADAMTS13, and for D187A and E212A also reduced the V(max) to approximately 25% of normal. Kinetic analysis of the Asp187 mutant in the presence of excess Ca(2+) revealed an approximately 13-fold reduction in specificity constant, k(cat)/K(m), contributed by changes in both K(m) and k(cat). These results were corroborated using plasma-purified VWF as a substrate. Together, our results demonstrate that a major influence of Ca(2+) upon ADAMTS13 function is mediated through binding to a high-affinity site adjacent to its active site cleft.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19047683     DOI: 10.1182/blood-2008-03-144683

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  The ADAMTS13 metalloprotease domain: roles of subsites in enzyme activity and specificity.

Authors:  Rens de Groot; David A Lane; James T B Crawley
Journal:  Blood       Date:  2010-07-20       Impact factor: 22.113

2.  ADAMTS13 and von Willebrand factor interactions.

Authors:  Catherine B Zander; Wenjing Cao; X Long Zheng
Journal:  Curr Opin Hematol       Date:  2015-09       Impact factor: 3.284

Review 3.  Structure-function and regulation of ADAMTS-13 protease.

Authors:  X L Zheng
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

4.  Role for telomerase in Listeria monocytogenes infection.

Authors:  Ascel Samba-Louaka; Fabrizia Stavru; Pascale Cossart
Journal:  Infect Immun       Date:  2012-09-24       Impact factor: 3.441

5.  Mechanism of von Willebrand factor scissile bond cleavage by a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13).

Authors:  Yaozu Xiang; Rens de Groot; James T B Crawley; David A Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-24       Impact factor: 11.205

Review 6.  Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor.

Authors:  James T B Crawley; Rens de Groot; Yaozu Xiang; Brenda M Luken; David A Lane
Journal:  Blood       Date:  2011-06-29       Impact factor: 22.113

7.  The role of the ADAMTS13 cysteine-rich domain in VWF binding and proteolysis.

Authors:  Rens de Groot; David A Lane; James T B Crawley
Journal:  Blood       Date:  2015-01-06       Impact factor: 22.113

8.  Next-Generation Sequencing and In Vitro Expression Study of ADAMTS13 Single Nucleotide Variants in Deep Vein Thrombosis.

Authors:  Maria Teresa Pagliari; Luca A Lotta; Hugoline G de Haan; Carla Valsecchi; Gloria Casoli; Silvia Pontiggia; Ida Martinelli; Serena M Passamonti; Frits R Rosendaal; Flora Peyvandi
Journal:  PLoS One       Date:  2016-11-01       Impact factor: 3.240

Review 9.  ADAM and ADAMTS Family Proteins and Snake Venom Metalloproteinases: A Structural Overview.

Authors:  Soichi Takeda
Journal:  Toxins (Basel)       Date:  2016-05-17       Impact factor: 4.546

Review 10.  ADAMTS-13 and von Willebrand factor: a dynamic duo.

Authors:  K South; D A Lane
Journal:  J Thromb Haemost       Date:  2017-12-02       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.